Page 143 - Read Online
P. 143

Spiliopoulou  et al. Cancer Drug Resist 2024;7:2  https://dx.doi.org/10.20517/cdr.2023.46  Page 11

                                                            Ratio was predictive in other tumor types as well, i.e.,
                                                            gastric cancer and melanoma
                                                       +
                Renal cell   43        Flow cytometry using CD4  Treatment with nivolumab reduced T  cells only in   Santagata et al.
                                                                                   reg
                                          +    -    +                                              [109]
                carcinoma              CD25 CD127 FOXP3     responders when assessed after 3 months   2020
                                                            Inhibition with CXCR4 antagonist blocked T  cell
                                                                                       reg
                                                            function in vitro
                                                            Treatment with nivolumab reduced T  cells only in
                                                                                   reg
                                                            responders when assessed after 3 months
                                                        +                               +
                Uveal     9            Mass cytometry using CD4  T  cells reduced within 3 months, while CD8  and NK  Di Giacomo et
                                                             reg
                                          +
                melanoma               CD25 CD127 -         cells increased                     al. 2022 [110]
               T  cells: T regulatory cells; FOXP3: forkhead box protein P3; OS: overall survival; IHC: immunohistochemistry; CCL: chemokine c-c-motif ligand;
                reg
               CCR: C-C chemokine receptor; NSCLC: non-small cell lung cancer; CTLA-4: cytotoxic T lymphocyte antigen-4; IL: interleukin; Th17 cells: T helper
               17 cells; TGF-β: transforming growth factor beta; EGFR: epidermal growth factor receptor; PD-1: programmed death 1; NK: natural killer.
               In 275 tumor specimens from patients with endometrial cancer, high FOXP3 expression was correlated with
               poor OS . A similar observation was reported for patients with primary breast cancer, where T  cells and
                      [93]
                                                                                                 reg
                                                                                [94]
               CCL5 were co-expressed with standard prognostic markers for breast cancer . The authors postulated that
               CCL5 engages the CCR5 on T  cells and subsequently induces the production of TGF-β . Like the CCL5/
                                                                                          [94]
                                         reg
               CCR5 axis, the chemokine receptor CCR8 (its ligand being CCL1) also plays a critical role in upregulating
               genes of intra-tumoral T  cells as observed in patients with breast, colorectal, and lung cancer [112,113] . In each
                                    reg
               of these tumor types, the expression of CCR8 correlated with T  cell signature and was associated with
                                                                       reg
                            [114]
               poor prognosis .
               Oncogenic driver mutations are associated with a tumor microenvironment rich in immunosuppressive
               mediators and T  cells. For instance, Epidermal Growth Factor Receptor (EGFR) mutations in NSCLC are
                             reg
               associated with high levels of T  cells . The microenvironment of patients with EGFR-mutated NSCLC is
                                               [102]
                                         reg
                                                                               [102]
               immune-suppressed, as indicated by tissue expression of FOXP3 and PD-L1 . Furthermore, high numbers
               of Fraction 2 T  cells, low numbers of CD8  T cells (i.e., non-inflamed condition), and high levels of CCL22
                                                    +
                            reg
               (the main ligand for CCR4) are observed in EGFR-mutated NSCLC patients . This immunosuppressive
                                                                                 [103]
               state was reversed during combination treatment of EGFR inhibitors and PD-1 monoclonal antibodies,
               leading to a reprogramming of the immune subsets, and consequently overcoming the resistance. Kirsten
               Rat Sarcoma Virus (KRAS) mutated tumors are also associated with high numbers of T  cells, for example,
                                                                                         reg
               in KRAS-mutated colorectal cancers . KRAS-mutated tumors produce the immune suppressive mediators
                                              [115]
                                                                                       [116]
               IL-10 and TGF-β1 and thus drive a phenotype switch from naïve to T  cells . Because of these
                                                                                 reg
               observations in EGFR- and KRAS-mutated tumors, it is possible that other mutations are associated with
                                                          [117]
               similar immunosuppressive mediators and T  cells .
                                                     reg
               In contrast to solid tumors, lymphoma patients may harbor four functionally distinct T  cell groups: (1)
                                                                                           reg
               Suppressor T  cells: similar to solid tumors, this group of T  cells is immunosuppressive; (2) Malignant
                                                                   reg
                           reg
               T  cells: the malignant clone derived from precursors of T cells expresses FOXP3 as a marker for adult T
                reg
               cell leukemia/lymphoma (ATLL) and cutaneous T-cell lymphomas (CTCL); (3) Direct tumor-killing T
                                                                                                        reg
               cells: T  cells with suppressive cytotoxicity capable of killing tumor cells; (4) Incompetent T  cells: mostly
                     reg
                                                                                              reg
               observed in angioimmunoblastic T-Cell lymphoma (AITL), and their presence is associated with
               autoimmune symptoms . These different groups with distinct functions were not considered in a recent
                                   [118]
               meta-analysis of 23 lymphoma studies. In this meta-analysis, high numbers of T  cells at baseline were
                                                                                     reg
               associated with improved survival . However, in some subsets of T cell lymphoma and follicular
                                              [119]
               lymphoma,  the  high  T   cell  counts  were  not  associated  with  improved  OS.  Hence,  additional
                                     reg
               differentiation markers are needed to accurately assess the functional role of T  cells in lymphoma and its
                                                                                  reg
               sub-types.
   138   139   140   141   142   143   144   145   146   147   148